Literature DB >> 8122352

Plasma levels of fenbendazole metabolites in buffalo and cattle after long-term intraruminal administration.

P K Sanyal1.   

Abstract

Plasma metabolite levels were measured in buffalo and cross-bred cattle after daily intraruminal administration of fenbendazole at 0.5 mg/kg body weight. An equilibrium between the absorption of fenbendazole and disposition of its metabolites could be observed between days 3 to 6 and remained almost unchanged thereafter. The buffaloes had a lower uptake of the anthelmintic and lower plasma levels of its metabolites than in cattle. The findings were compared with those obtained after a single intraruminal therapeutic dose of fenbendazole.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8122352     DOI: 10.1080/01652176.1993.9694396

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  5 in total

1.  Administration of fenbendazole in urea molasses block to dairy buffaloes in India.

Authors:  P K Sanyal; D K Singh
Journal:  Trop Anim Health Prod       Date:  1995-08       Impact factor: 1.559

2.  The efficacy and pharmacokinetics of long-term low-level intraruminal administration of triclabendazole in buffalo with induced fasciolosis.

Authors:  P K Sanyal; S C Gupta
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

3.  The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.

Authors:  P K Sanyal
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

4.  Influence of subclinical nematodosis on the kinetic disposition of fenbendazole in buffaloes.

Authors:  A C Mathur; P K Sanyal; S Sarkar
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

5.  Formulation and Evaluation of Fenbendazole Extended-Release Extrudes Processed by Hot-Melt Extrusion.

Authors:  Gilberto S N Bezerra; Tielidy A de M de Lima; Declan M Colbert; Joseph Geever; Luke Geever
Journal:  Polymers (Basel)       Date:  2022-10-06       Impact factor: 4.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.